Resources Contact Us Home
Method for selecting compounds for treating ischemia-related cellular damage

Image Number 12 for United States Patent #6379882.

A method of screening for and treating subjects with a therapeutically effective amount of a compound that is effective in reducing cellular damage related to an ischemic condition, such as stroke or glaucoma. Test compounds are selected and therapeutically effective amount determined based on the relative efficacy of test compounds in preventing cell death in primary cultures of excitable cells, such as retinal ganglion cells, in vitro.

  Recently Added Patents
Specializing disambiguation of a natural language expression
Quaternary chalcogenide wafers
Fabrication of thin pellicle beam splitters
Bi-directional, compact, multi-path and free space channel replicator
Optoelectronic semiconductor chip comprising a reflective layer
Radio transmitter and radio receiver with channel condition assessment
Battery module
  Randomly Featured Patents
Ignition coil for internal-combustion engine
Lift platform for road vehicles and trailers
Personal securing apparatus for handheld devices
Piercing apparatus
Semiconductor laser device
Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
Communication system
Tilt-dependent beam-shape system
Device for protecting rims in glass or ceramic bodies
Heat exchanger stack apparatus